AJP - Regu Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 297: R1375-R1382, 2009. First published August 26, 2009; doi:10.1152/ajpregu.00284.2009
0363-6119/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/5/R1375    most recent
00284.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Horn, C. C.
Right arrow Articles by Norgren, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horn, C. C.
Right arrow Articles by Norgren, R.

Articles

Chemotherapy-induced kaolin intake is increased by lesion of the lateral parabrachial nucleus of the rat

Charles C. Horn,1,3 Bart C. De Jonghe,1 Kathleen Matyas,2 and Ralph Norgren2

1Monell Chemical Senses Center, Philadelphia, Pennsylvania; 2Department of Neural and Behavioral Sciences, The Pennsylvania State University, College of Medicine, Hershey, Pennsylvania; 3University of Pittsburgh Cancer Institute, Biobehavioral Medicine in Oncology Program; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition; and Department of Anesthesiology, Pittsburgh, Pennsylvania

Submitted May 21, 2009 ; accepted in final form August 24, 2009

Anticancer agents, such as cisplatin, stimulate nausea, vomiting, and behaviors indicative of malaise. Rats and mice do not possess a vomiting response, and, therefore, in these species, the ingestion of kaolin clay (a pica response) has been used as an index of malaise. In the rat, cisplatin-induced kaolin intake is inhibited by antiemetic treatments. In addition, cisplatin activates vagal afferent fibers in the gut, and kaolin intake induced by cisplatin is largely dependent on an intact vagus. Nevertheless, little is known about the brain pathways controlling pica. We investigated the role of the lateral parabrachial nucleus (lPBN), a major visceral afferent link between the hindbrain and forebrain, in cisplatin-induced c-Fos expression and pica. Injection of cisplatin (6 mg/kg ip) produced c-Fos expression in the ventrolateral (external) lPBN, a region receiving viscerosensory input. In rats with bilateral ibotenic acid lPBN lesions, cisplatin treatment substantially increased kaolin intake compared with controls (~30 g vs. ~5 g, respectively, over 24 h). Food intake was reduced by cisplatin treatment and by apomorphine, an emetic agent that acts centrally. Unlike cisplatin, however, apomorphine stimulated kaolin intake to a similar degree in both the lesioned and control rats, suggesting that lPBN damage neither produces nonspecific effects nor enhances malaise in general. These data suggest that lPBN-lesioned animals not only demonstrate pica after cisplatin treatment, but, in fact, show an exaggerated response that is greatly in excess of any treatment known to produce kaolin intake in rats.

emesis; nausea; pica; vagus; anorexia



Address for reprint requests and other correspondence: C. C. Horn, Univ. of Pittsburgh Cancer Institute, Hillman Cancer Center-Research Pavilion, G.17b, Biobehavioral Medicine in Oncology Program, 5117 Centre Ave., Pittsburgh, PA 15213 (e-mail: chorn{at}pitt.edu).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.